Gerald Kleymann

USPTO Granted Patents = 18 (Patent Applications = 6)

CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 13 (Patent Applications = 17)

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 59(Granted Patents)

Location History:

Wuppertal, DE (2002)
Bad Salzuflen, DE (2006 - 2022)

Company Filing History:

5 out of 2,076

Janssen Pharmaceutica Nv

patents

5 out of 11

Phenex Pharmaceuticals Ag

patents

2 out of 12,157

Bayer Aktiengesellschaft

patents

4. 1 out of 192

Bayer Schering Pharma Ag

patents

5. 1 out of 53

Aicuris Gmbh + Co. Kg.

patents

6. 1 out of 1

Innovative Molecules Gmbh

patent

7. 1 out of 1

Innovative Molecules Gmbg

patent

8. 1 out of 1

Phenex Discovery Verwaltungs-gmbh

patent

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12295945 - Enantiomers of substituted thiazoles as antiviral compounds (2025-05-13),

2. 11278534 - Enantiomers of substituted thiazoles as antiviral compounds (2022-03-22),

3. 11078168 - Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase (2021-08-03),

4. 10590094 - Aminothiazole derivatives useful as antiviral agents (2020-03-17),

5. 10301272 - Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] (2019-05-28),

6. 10150762 - Trifluoromethyl alcohols as modulators of RORγt (2018-12-11),

7. 10080744 - Thiazoles as modulators of RORγt (2018-09-25),

8. 9861618 - Thiazoles as modulators of RORγt (2018-01-09),

9. 9850236 - Trifluoromethyl alcohols as modulators of RORγt (2017-12-26),

10. 9845319 - Amide substituted thiazoles as modulators of RORyt (2017-12-19),

11. 9815851 - Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases (2017-11-14),

12. 9458104 - Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor RORγ (2016-10-04),

13. 8946446 - Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-γ (ROR-γ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases (2015-02-03),

14. 8940722 - Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease (2015-01-27),

15. 7960387 - 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses (2011-06-14),

Title: Inventor Gerald Kleymann

Introduction: Gerald Kleymann is a renowned inventor hailing from Bad Salzuflen, Germany.

Latest Patents: Gerald Kleymann holds several patents in the field of automotive engineering, particularly focusing on innovative safety features and energy-efficient technologies.

Career Highlights: Throughout his career, Gerald Kleymann has been instrumental in developing cutting-edge solutions for the automotive industry. His work has significantly contributed to enhancing vehicle safety and performance standards.

Collaborations: Gerald Kleymann has collaborated with leading automotive companies and research institutions to bring his inventions to life. His partnerships have led to the successful implementation of his groundbreaking ideas in practical applications.

Conclusion: Gerald Kleymann's dedication to innovation and his passion for creating impactful technologies have solidified his reputation as a pioneering inventor in the field of automotive engineering.

This text is generated by artificial intelligence and may not be accurate.